Comments
Loading...
Number of Stock Holdings
59
Number of Bond Holdings
-
Total Holdings
59
Number of ETFs
-
Franklin Genomic Advancements ETF (BATS:HELX), Top Holdings
Franklin Genomic Advancements ETF (BATS: HELX)
| Ticker | Name | Share % | |
|---|---|---|---|
| MEDP | Medpace Holdings Inc | 6.31% | |
| VRTX | Nvaesrtex Pharmaceuticals Inc | 5.51% | |
| REGN | Regeneron Pharmaceuticals, Inc. | 5.18% | |
| DHR | Danaher Corp. | 5.14% | |
| TMO | Thermo Fisher Scientific Inc | 4.85% | |
| KRYS | Krystal Biotech Inc | 4.80% | |
| LLY | Eli Lilly & Co. | 4.17% | |
| KR | Samsung Biologics Co Ltd | 3.30% | |
| NTRA | Natera Inc | 3.04% | |
| LN | Astrazeneca Plc, ADR | 2.60% | |
FAQ
How has HELX ETF performed?
Quote.FAQ.Answers.ETFs.etf-performance
What is the expense ratio for HELX?
Quote.FAQ.Answers.ETFs.expense-ratio
What is the Assets Under Management (AUM) for HELX?
Quote.FAQ.Answers.ETFs.aum
What is the investment style for HELX?
HELX follows a Mid Cap Growth investment style.
What are the top holdings for HELX?
The top holdings of HELX include: MEDP (6.31%), VRTX (5.51%), REGN (5.18%), DHR (5.14%), TMO (4.85%). These represent the largest positions in the ETF's portfolio.
What is the average daily trading volume for HELX?
Average daily volume data for HELX is currently not available.